Sonoma Biotherapeutics
Jill McGuire is an experienced finance professional who has held various finance roles at Sangamo Therapeutics, Inc. before becoming the Head of Financial Planning at Principia Biopharma. Currently, Jill serves as the Head of Finance at Sonoma Biotherapeutics. McGuire graduated from the University of California, Berkeley.
This person is not in any offices
Sonoma Biotherapeutics
1 followers
Sonoma Biotherapeutics is developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases driven by an imbalanced immune system. Founded by pioneers in Treg biology and cell therapy, the company is employing proprietary platform technologies and approaches to develop a new generation of targeted Treg cell therapies designed to induce durable immune tolerance to treat and prevent autoimmune and inflammatory diseases. Sonoma Biotherapeutics is based in South San Francisco and Seattle.